Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Fujitsu, Ltd. | Equity | 4,685,000 | $723,733,155.00 | 6.38% |
Capital Group Central Cash Fund | Short Term | 5,315,925 | $531,592,464.00 | 4.68% |
Novo Nordisk AS, Class B | Equity | 2,830,508 | $335,582,549.00 | 2.96% |
Broadcom, Inc. | Equity | 240,990 | $313,405,085.00 | 2.76% |
Microsoft Corp. | Equity | 651,713 | $269,574,565.00 | 2.38% |
ASML Holding NV | Equity | 251,857 | $236,528,711.00 | 2.08% |
Safran SA | Equity | 1,071,982 | $224,015,556.00 | 1.97% |
AstraZeneca PLC | Equity | 1,513,059 | $190,646,090.00 | 1.68% |
Apple, Inc. | Equity | 984,057 | $177,868,303.00 | 1.57% |
TotalEnergies SE | Equity | 2,735,629 | $174,099,153.00 | 1.53% |
SAP SE | Equity | 826,141 | $154,084,869.00 | 1.36% |
Abbott Laboratories | Equity | 1,156,141 | $137,164,568.00 | 1.21% |
Bristol-Myers Squibb Co. | Equity | 2,567,068 | $130,278,701.00 | 1.15% |
Hilton Worldwide Holdings, Inc. | Equity | 628,117 | $128,336,865.00 | 1.13% |
L'Oreal SA, non-registered shares | Equity | 267,111 | $127,285,882.00 | 1.12% |